Rheumatologist, Clinical Trialist, and Epi Researcher studying #Sarcoidosis, #IgG4RD, #Sjogrens, #RA. Associate Division Chief of Rheumatology @StanfordDeptMed
Stanford, CA
Joined October 2017
- Tweets170
- Following1.2K
- Followers526
- Likes2.8K
Matthew Baker M.D., M.S. retweeted
Wonderful to have the @IgG4ward Foundation BayJAM hosted by @mbake013 at @StanfordMed, increasing awareness and education for IgG4-related disease! @StanfordDeptMed
Matthew Baker M.D., M.S. retweeted
A trial co-led by @StanfordMed researchers, including #StanDOM's @mbake013, indicates a new drug can be used to effectively treat patients with IgG4-related disease (#IgG4RD), a rare chronic immune condition often misdiagnosed as cancer. stan.md/4erKpVa
ALT In IgG4-related disease, B cells (pictured) attack the body's own tissue. A study led by Stanford Medicine has found that a drug reduces the chance of relapse.
Matthew Baker M.D., M.S. retweeted
Excited to have participated in this #Delphi study for the management of 🫀#sarcoidosis, just published in @JACCJournals. Covers lots of controversial topics in #sarcoid management. sciencedirect.com/science/ar…
Matthew Baker M.D., M.S. retweeted
Such a wonderful evening getting together for the Division of Immunology and Rheumatology Holiday Party! 🎉 🎄 We are excited for a collaborative and productive 2025!
Matthew Baker M.D., M.S. retweeted
⚠️ NEW @OACJournal
#DrugRepurposing
Can repurposing existing drugs 💊 for #osteoarthritis treatment improve existing outcomes? #diseasemodification #DMOAD #rheumatology
Read more from @mbake013 @WKuswanto @StanfordRheum @StanfordMed 👇
tinyurl.com/2u2yxaeb
Matthew Baker M.D., M.S. retweeted
Proud to announce that we are now an R01 funded lab! We will be using single cell multi-omics in human samples & mouse models to test novel therapeutic pathways in cardiac sarcoidosis. #cardioimmunology @nih_nhlbi @NIH @StanfordCVI @StanfordDeptMed @Joseph_C_Wu @SeanM_Wu @EldrinL
Matthew Baker M.D., M.S. retweeted
We are thrilled to announce our new Chair of the Stanford Department of Medicine, Dr. Euan Ashley @euanashley . We have a great future ahead!!! Dr. Ashley becomes Chair Sept 18th, 2024.
Matthew Baker M.D., M.S. retweeted
Inebilizumab hit its primary and key secondary endpoints for #IgG4RD. Huge moment for the IgG4-RD community! Looking forward to full results. wwwext.amgen.com/newsroom/pr…..
Matthew Baker M.D., M.S. retweeted
Check out this latest publication! The Robinson lab demonstrated a key role for coagulation pathways in the development of osteoarthritis- read more about the work as published in JCI Insight. @StanfordMed #immunology #osteoarthritis #rheumatology
insight.jci.org/articles/vie…
Will be great to see you @itchdoctor ! – at West Menlo Park, CA
Looking forward to the @StanfordMed #autoimmunity #allergy conference next week - see you soon @mbake013
iti.stanford.edu/events.html
Matthew Baker M.D., M.S. retweeted
Adding to the narrative that allergic diseases may contribute to #osteoarthritis, @mbake013 and colleagues found that genetic risk for atopic disease was associated with knee OA in a Mendelian randomization study.
@QOstrom @wrobins111
📖 bit.ly/3UqgFQa
Matthew Baker M.D., M.S. retweeted
This day, now a decade ago.
👇🏾
December 20, 2013
Senior Assistant Residents
Department of Medicine
Massachusetts General Hospital
CC: @mghmedres – at Boston, MA
Matthew Baker M.D., M.S. retweeted
Congratulations to our new first year Stanford Rheumatology fellows! @stanfordmed #rheumatology
Matthew Baker M.D., M.S. retweeted
A recent small placebo-cont'd #RCT of IL6R inhibitor #sarilumab for #sarcoidosis found no benefit despite plausible biology.
Is a larger RCT needed? Can we predict what that RCT might find?
🚨Human genetic data do 𝐧𝐨𝐭 support IL6Ri for sarcoidosis academic.oup.com/rheumatolog…
Such a fun and memorable #ACR2023. Great to catch up with old friends and meet new collaborators! – at San Diego, CA
Matthew Baker M.D., M.S. retweeted
Impressive and important study supporting safety of TNF inhibitors among patients with RA-ILD. Elegant methods of target trial emulation. Congrats to the authors on plenary presentation!
#ACR23
Matthew Baker M.D., M.S. retweeted
Don't miss Dr. Horomanski's @HoromanskiMd plenary lecture on pregnancy outcomes in vasculitis at ACR!! #ACR23 #Rheumatology #vasculitis #pregnancy @StanfordMed
Matthew Baker M.D., M.S. retweeted
When Einthoven introduced the ECG to the world, he uniquely labeled its parts PQRST, inspired by mathematicians who used Ps & Qs in coordinates. Yet, he believed there was more to find, so he started in the alphabet's middle, leaving room for new discoveries on both sides.
1/n
Matthew Baker M.D., M.S. retweeted
Join Dr. Baker @mbake013 at ACR for back-to-back oral presentations exploring vagus nerve involvement in RA. #ACR23 #rheumatology #rheumatoidarthritis @stanfordmed
Matthew Baker M.D., M.S. retweeted
Our Division Chief Bill Robinson @wrobins111 giving a talk yesterday at yesterday at Hot Topic 1 session of #MSMilan2023 outlining evidence for and against #EBV as the cause for all #MultipleSclerosis. #rheumatology #immunology @StanfordMed
